Business
Maxim Group Reiterates Bullish Stance on Strive (ASST), Sees 50% Upside to $1.50 Target
Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.